| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| N Thiriet, D Aunis, J Zwille. C-fos and egr-1 immediate-early gene induction by cocaine and cocaethylene in rat brain: a comparative study. Annals of the New York Academy of Sciences. vol 914. 2006-01-04. PMID:11085307. |
since cocaine is known to potently inhibit both dopamine and serotonin transporters, whereas cocaethylene only inhibits the dopamine transporter, our results strongly suggest that the serotonergic system participates in the mode of action of cocaine in its ability to trigger immediate-early gene transcription. |
2006-01-04 |
2023-08-12 |
rat |
| Roger L H Pobbe, Hélio Zangross. 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology. vol 183. issue 3. 2006-01-04. PMID:16231166. |
5-ht(1a) and 5-ht(2a) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. |
2006-01-04 |
2023-08-12 |
rat |
| Swen Hesse, Ulrich Müller, Thomas Lincke, Henryk Barthel, Thomas Villmann, Matthias C Angermeyer, Osama Sabri, Katarina Stengler-Wenzk. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry research. vol 140. issue 1. 2006-01-03. PMID:16213689. |
in obsessive-compulsive disorder (ocd), the success of pharmacological treatment with serotonin re-uptake inhibitors and atypical antipsychotic drugs suggests that both the central serotonergic and dopaminergic systems are involved in the pathophysiology of the disorder. |
2006-01-03 |
2023-08-12 |
Not clear |
| Joseph I Friedman, Ramoncito Ocampo, Zeinab Elbaz, Michael Parrella, Leonard White, Stephanie Bowler, Kenneth L Davis, Philip D Harve. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia. Journal of clinical psychopharmacology. vol 25. issue 3. 2005-12-30. PMID:15876902. |
because serotonergic approaches have been suggested as a possible mechanism to enhance cognition and many patients with schizophrenia are treated with selective serotonin reuptake inhibitor antidepressants, we evaluated a serotonin reuptake inhibitor, citalopram, as adjunctive therapy to atypical antipsychotic treatment for its cognitive enhancing effects in schizophrenic patients. |
2005-12-30 |
2023-08-12 |
human |
| Xianwu Zheng, Shinjae Chung, Takahiro Tanabe, Ji Ying Sz. Cell-type specific regulation of serotonergic identity by the C. elegans LIM-homeodomain factor LIM-4. Developmental biology. vol 286. issue 2. 2005-12-29. PMID:16168406. |
in order to delineate the molecular mechanisms of serotonergic phenotype establishment, we have screened for neuron-specific serotonin deficient (nss) mutants. |
2005-12-29 |
2023-08-12 |
caenorhabditis_elegans |
| J B Fan, P Skla. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Molecular psychiatry. vol 10. issue 10. 2005-12-23. PMID:15940296. |
the serotonin transporter gene (slc6a4) is a candidate gene for schizophrenia based on serotonin transporter's crucial role in serotonergic neurotransmission. |
2005-12-23 |
2023-08-12 |
human |
| Daniel E Rusyniak, Jon E Spragu. Toxin-induced hyperthermic syndromes. The Medical clinics of North America. vol 89. issue 6. 2005-12-22. PMID:16227063. |
serotonin syndrome typically occurs within hours of the addition ofa new serotonergic agent or the abuse of stimulants such as mdma or methamphetamine. |
2005-12-22 |
2023-08-12 |
Not clear |
| Nallini Gnanadesigan, Randall T Espinoza, Rick Smith, Michelle Israel, David B Reube. Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected? Journal of the American Medical Directors Association. vol 6. issue 4. 2005-12-20. PMID:16005413. |
interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? |
2005-12-20 |
2023-08-12 |
Not clear |
| Nallini Gnanadesigan, Randall T Espinoza, Rick Smith, Michelle Israel, David B Reube. Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected? Journal of the American Medical Directors Association. vol 6. issue 4. 2005-12-20. PMID:16005413. |
to describe the potential for interaction between opioids and serotonergic antidepressants leading to the development of serotonin syndrome (ss), mechanism of the interaction, and the spectrum of ss in elderly residents of a long-term care facility. |
2005-12-20 |
2023-08-12 |
Not clear |
| Rivelilson Mendes de Freitas, Lissiana M V Aguiar, Silvânia M M Vasconcelos, Francisca C F Sousa, Glauce S B Viana, Marta M F Fontele. Modifications in muscarinic, dopaminergic and serotonergic receptors concentrations in the hippocampus and striatum of epileptic rats. Life sciences. vol 78. issue 3. 2005-12-20. PMID:16137708. |
the present study was undertaken in order to investigate the muscarinic (m(1)), dopaminergic (d(1) and d(2)) and serotonergic (5-ht(2)) receptors densities in hippocampus and striatum of wistar rats after status epilepticus (se) induced by pilocarpine. |
2005-12-20 |
2023-08-12 |
rat |
| G Telegdy, H Tiricz, A Adami. Involvement of neurotransmitters in urocortin-induced passive avoidance learning in mice. Brain research bulletin. vol 67. issue 3. 2005-12-15. PMID:16144661. |
d2, muscarinic cholinergic, alfa-adrenergic, crf, serotonergic (5ht 1-2), gaba b receptors are involved in the consolidation of the passive avoidance response. |
2005-12-15 |
2023-08-12 |
mouse |
| David S Paterson, Eric G Thompson, Richard A Belliveau, Bobbie A Antalffy, Felicia L Trachtenberg, Dawna D Armstrong, Hannah C Kinne. Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in Rett syndrome: potential implications for clinical autonomic dysfunction. Journal of neuropathology and experimental neurology. vol 64. issue 11. 2005-12-15. PMID:16254496. |
this gene plays a role in regulating neuronal activity-dependent gene expression, including brain-derived neurotrophic factor (bdnf), which is a potent serotonergic (5-ht) neuronal growth factor. |
2005-12-15 |
2023-08-12 |
mouse |
| Michael M Scott, Christi J Wylie, Jessica K Lerch, Roxanne Murphy, Katherine Lobur, Stefan Herlitze, Weihong Jiang, Ron A Conlon, Ben W Strowbridge, Evan S Deneri. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proceedings of the National Academy of Sciences of the United States of America. vol 102. issue 45. 2005-12-12. PMID:16251278. |
serotonin (5ht) is a critical modulator of neural circuits that support diverse behaviors and physiological processes, and multiple lines of evidence implicate abnormal serotonergic signaling in psychiatric pathogenesis. |
2005-12-12 |
2023-08-12 |
mouse |
| Michael M Scott, Christi J Wylie, Jessica K Lerch, Roxanne Murphy, Katherine Lobur, Stefan Herlitze, Weihong Jiang, Ron A Conlon, Ben W Strowbridge, Evan S Deneri. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proceedings of the National Academy of Sciences of the United States of America. vol 102. issue 45. 2005-12-12. PMID:16251278. |
the significance of 5ht underscores the importance of elucidating the molecular pathways involved in serotonergic system development, function, and plasticity. |
2005-12-12 |
2023-08-12 |
mouse |
| Paul A Sykes, Barry G Condro. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Developmental biology. vol 286. issue 1. 2005-12-07. PMID:16122730. |
development and sensitivity to serotonin of drosophila serotonergic varicosities in the central nervous system. |
2005-12-07 |
2023-08-12 |
drosophila_melanogaster |
| Paul A Sykes, Barry G Condro. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Developmental biology. vol 286. issue 1. 2005-12-07. PMID:16122730. |
in this study, we show that serotonin can modulate the development of serotonergic varicosities within the fly central nervous system. |
2005-12-07 |
2023-08-12 |
drosophila_melanogaster |
| Paul A Sykes, Barry G Condro. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Developmental biology. vol 286. issue 1. 2005-12-07. PMID:16122730. |
we hypothesize that serotonin is an autoregulator for serotonergic varicosity density. |
2005-12-07 |
2023-08-12 |
drosophila_melanogaster |
| Paul A Sykes, Barry G Condro. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Developmental biology. vol 286. issue 1. 2005-12-07. PMID:16122730. |
we tested the sensitivity of serotonergic varicosities to serotonin by adding neurotransmitter at various stages to isolated larval ventral nerve cords. |
2005-12-07 |
2023-08-12 |
drosophila_melanogaster |
| Paul A Sykes, Barry G Condro. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Developmental biology. vol 286. issue 1. 2005-12-07. PMID:16122730. |
the effects of serotonin appear to be selective for serotonergic varicosities, as dopaminergic and corazonergic varicosities remain qualitatively intact following serotonin application. |
2005-12-07 |
2023-08-12 |
drosophila_melanogaster |
| Murat Kesim, Erdem N Duman, Mine Kadioglu, Ersin Yaris, Nuri I Kalyoncu, Nesrin Erciye. The different roles of 5-HT(2) and 5-HT(3) receptors on antinociceptive effect of paroxetine in chemical stimuli in mice. Journal of pharmacological sciences. vol 97. issue 1. 2005-12-05. PMID:15655293. |
peripheral serotonergic mechanisms/receptors may contribute to this antinociceptive effect, especially by 5-ht(3)-receptor subtypes. |
2005-12-05 |
2023-08-12 |
mouse |